Abstract
This work presents the preliminary data of one center study of the total activity of adenosine deaminase (tADA) and its isoforms (ADA1 and ADA2) in the blood plasma of patients with type 2 diabetes mellitus (T2DM), including cases with complication with arterial hypertension. As a nonspecific indicator of cellular immunity, altered serum tADA activity is used to evaluate diseases related to cell-mediated immune responses, it is considered a useful tool in the monitoring of clinical status of various diseases.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: “Katchar” Collection of Scientific Articles International Scientific-Educational Center NAS RA
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
